Application no. and date | 10163527.4 (espacenet) (Federated) (European Patent Register), 20040924 | Patent/reg. no. and date | DK/EP 2263694, 20130612 | Publication date | 20101222 | Priority no. and date | JP 2003334340, 20030925, JP 2003344315, 20031002 | EP pub. no. and date |
EP 2263694 20101222 | Effective date | | Applicant/owner | Astellas Pharma Inc., 2-5-1, Nihonbashi-Honcho Chuo-ku Tokyo 103-8411, JP | Applicant ref. no. | 157571 | Inventor | Naoe, Yoshinori, c/o The Section of Immunology Department of Mechanism of Aging Research Institute National Center for Geriatrics and Gerontology 35 Gengo Morioka-machi
Obu City Aichi 474-8511, JP, Sasakawa, Yuka, c/o Astellas Pharma Inc. 3-11 Nihonbashi-Honcho 2-chome, Chuo-ku
Tokyo 103-8411, JP | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | Opponent | | IPC Class | A61K 31/704 (2006.01) , A61K 38/12 (2006.01) , C07K 11/02 (2006.01) | Title | Antitumormiddel omfattende histon-deacetylase-inhibitoren FK228 og topoisomerase-II-inhibitoren doxorubicin | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|